These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19346015)

  • 1. Is warfarin still underused in patients with atrial fibrillation? A major threat to treatment benefit.
    Baysan O; Yokusoglu M; Bugan B
    Int J Cardiol; 2010 Oct; 144(3):439-40. PubMed ID: 19346015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR; Fang MC
    Clin Geriatr Med; 2012 Nov; 28(4):617-34. PubMed ID: 23101573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
    Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
    J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 10. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke.
    Sanoski CA
    J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent development of anticoagulation in stroke prevention for atrial fibrillation].
    Suzuki S; Yamashita T
    Nihon Rinsho; 2014 Jul; 72(7):1282-6. PubMed ID: 25163322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing stroke in atrial fibrillation: the SPORTIF programme.
    Lip GY
    Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?
    Baruch L; Gage BF; Horrow J; Juul-Möller S; Labovitz A; Persson M; Zabalgoitia M
    Stroke; 2007 Sep; 38(9):2459-63. PubMed ID: 17673721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.